↓ Skip to main content

Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study

Overview of attention for article published in Orphanet Journal of Rare Diseases, January 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
10 tweeters
googleplus
1 Google+ user

Citations

dimensions_citation
95 Dimensions

Readers on

mendeley
75 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study
Published in
Orphanet Journal of Rare Diseases, January 2013
DOI 10.1186/1750-1172-8-177
Pubmed ID
Authors

Tetsuo Ashizawa, Karla P Figueroa, Susan L Perlman, Christopher M Gomez, George R Wilmot, Jeremy D Schmahmann, Sarah H Ying, Theresa A Zesiewicz, Henry L Paulson, Vikram G Shakkottai, Khalaf O Bushara, Sheng-Han Kuo, Michael D Geschwind, Guangbin Xia, Pietro Mazzoni, Jeffrey P Krischer, David Cuthbertson, Amy Holbert, John H Ferguson, Stefan M Pulst, SH Subramony

Abstract

All spinocerebellar ataxias (SCAs) are rare diseases. SCA1, 2, 3 and 6 are the four most common SCAs, all caused by expanded polyglutamine-coding CAG repeats. Their pathomechanisms are becoming increasingly clear and well-designed clinical trials will be needed.

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 1%
Belgium 1 1%
Canada 1 1%
Brazil 1 1%
Unknown 71 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 20%
Researcher 13 17%
Student > Master 9 12%
Professor > Associate Professor 6 8%
Other 5 7%
Other 12 16%
Unknown 15 20%
Readers by discipline Count As %
Medicine and Dentistry 17 23%
Neuroscience 13 17%
Agricultural and Biological Sciences 11 15%
Nursing and Health Professions 6 8%
Biochemistry, Genetics and Molecular Biology 6 8%
Other 6 8%
Unknown 16 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 September 2020.
All research outputs
#3,882,438
of 22,731,677 outputs
Outputs from Orphanet Journal of Rare Diseases
#505
of 2,604 outputs
Outputs of similar age
#41,418
of 280,769 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#17
of 94 outputs
Altmetric has tracked 22,731,677 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,604 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 280,769 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.